Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Can-Fite Biopharma Ltd ADR (CANF)

Can-Fite Biopharma Ltd ADR (CANF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,505
  • Shares Outstanding, K 20,067
  • Annual Sales, $ 760 K
  • Annual Income, $ -14,440 K
  • 60-Month Beta 1.93
  • Price/Sales 41.03
  • Price/Cash Flow N/A
  • Price/Book 6.78
Trade CANF with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.10
  • Number of Estimates 1
  • High Estimate -0.10
  • Low Estimate -0.10
  • Prior Year -0.24
  • Growth Rate Est. (year over year) +58.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4800 +6.08%
on 10/06/21
1.7400 -9.77%
on 09/27/21
-0.0800 (-4.85%)
since 09/21/21
3-Month
1.4800 +6.08%
on 10/06/21
2.2399 -29.91%
on 07/22/21
-0.6100 (-27.98%)
since 07/21/21
52-Week
1.4800 +6.08%
on 10/06/21
4.3900 -64.24%
on 03/16/21
-0.2100 (-11.80%)
since 10/21/20

Most Recent Stories

More News
Positive Data from Phase IIa Can-Fite NASH Study Published in Leading Peer Reviewed Scientific Journal

Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today...

CANF : 1.5700 (+0.64%)
CFBI : 10.08 (-0.30%)
Can-Fite to Present at H.C. Wainwright 5th Annual NASH Investor Conference on October 12, 2021

Can-Fite BioPharma Ltd. (NYSE American:CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced...

CANF : 1.5700 (+0.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Can Fite Biopharma Ltd. is a biopharmaceutical company. It is focused on developing drugs for the treatment of cancer and autoimmune inflammatory diseases. The Company's lead drug candidate, CF101, is in clinical development for the treatment of autoimmune inflammatory diseases. Its CF102 drug candidate...

See More

Key Turning Points

3rd Resistance Point 1.7600
2nd Resistance Point 1.7100
1st Resistance Point 1.6400
Last Price 1.5700
1st Support Level 1.5200
2nd Support Level 1.4700
3rd Support Level 1.4000

See More

52-Week High 4.3900
Fibonacci 61.8% 3.2784
Fibonacci 50% 2.9350
Fibonacci 38.2% 2.5916
Last Price 1.5700
52-Week Low 1.4800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar